140 likes | 153 Vues
The global enteric disease testing market size reached US$ 3.9 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 4.8 Billion by 2027, exhibiting a growth rate (CAGR) of 3.57% during 2022-2027.<br>More info:- https://www.imarcgroup.com/enteric-disease-testing-market
E N D
Global Enteric Disease Testing Market Research and Forecast Report 2022-2027 Author: Elena Anderson Marketing Manager Copyright © IMARC Service Pvt Ltd. All Rights Reserved IMARC Group © 2022 IMARC All Rights Reserved
Report DescriptionAbout IMARC Group International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all regions and industry verticals to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
Report Description and Highlights Report Description Global Enteric Disease Testing Market Research Report 2022-2027: According to the latest IMARC Group report, titled “Enteric Disease Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, the global enteric disease testing market reached a value of US$ 3.9 Billion in 2021. Enteric diseases are caused by the ingestion of food or water contaminated by microbial toxins and microorganisms. These microorganisms enter through the mouth by coming in contact with an infected person's feces or with animals and their environments, attacking the gastrointestinal tract. Enteric diseases can cause symptoms like diarrhea, nausea, vomiting, fever, chills, abdominal cramps, and a loss of appetite. In recent years, the approval for the commercialization of novel technologies and the launch of new products have revolutionized enteric disease testing. Request for a PDF sample of this report: https://www.imarcgroup.com/enteric-disease-testing- market/requestsample
Report Description and Highlights Report Description Global Enteric Disease Testing Market Trends: The increasing cases of enteric diseases, such as cholera, amebiasis, Campylobacteriosis and Hepatitis A, represent the primary factor that positively impacts the global enteric disease testing market. This can be attributed to the unhygienic conditions, unsafe drinking water and poor sanitation. Besides this, with the recent outbreak of coronavirus disease (COVID-19), testing for enteric diseases has increased as the virus is variably found in human enteric samples during the course of infection. As a result, many healthcare centers are undertaking research to discover the co-relation between enteric disease and COVID-19. Furthermore, as individuals are becoming more aware of the benefits of early diagnosis, they are increasingly opting for the testing of enteric diseases. The leading healthcare companies are investing in research and development (R&D) activities to advance the enteric disease testing technologies to increase the efficiency of diagnosis. Some of the other factors, such as improving healthcare infrastructure, various technological advancements and the emerging trend of medical tourism, are expected to create a positive outlook for the market. Looking forward, the market is expected to grow at a CAGR of 3.57% during 2022-2027. View Report TOC, Figures and Tables: https://www.imarcgroup.com/enteric-disease-testing- market/requestsample
Report Description and Highlights Report Description Key Market Segmentation The research report includes the following segments: Breakup by Disease Type: •Bacterial Enteric Disease • C. Difficile • Campylobacteriosis • Cholera • E. Coli • H. Pylori • Salmonellosis • Shigellosis •Viral Enteric Disease • Rotavirus • Norovirus • Others •Parasitic Enteric Disease • Amebiasis • Cryptosporidiosis • Giardiasis
Report Description and Highlights Report Description Breakup by Product Type: •Reagents and Consumables •Equipment Breakup by Technique: •Molecular Diagnostics •Immunodiagnostics Breakup by End User: •Hospital Diagnostic Laboratories •Independent Diagnostic Laboratories •Academic and Research Institutes •Others Breakup by Region: •North America •Asia Pacific •Europe •Latin America •Middle East and Africa
Report Description and Highlights Report Description Competitive Landscape with Key Players: •Abbott Laboratories •BD (Becton, Dickinson and Company) •Bio-Rad Laboratories Inc. •Biomerica Inc. •Biomérieux SA •Cepheid Inc. (Danaher Corporation) •Coris BioConcept •DiaSorin •Meridian Bioscience Inc. •Quest Diagnostics.
Key Questions Answered in the Report Report Description 1. How has the global enteric disease testing market performed so far and how will it perform in the coming years? What are the key regional markets? What has been the impact of COVID-19 on the global enteric disease testing market? What is the breakup of the market based on the product type? What is the breakup of the market based on the technique? What is the breakup of the market based on the disease type? What is the breakup of the market based on the end user? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the industry? 10. What is the structure of the global enteric disease testing market and who are the key players? 11. What is the degree of competition in the industry? 2. 3. 4. 5. 6. 7. 8. 9.
Report DescriptionTable of Contents 1 Preface 2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Enteric Disease Testing Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast
Report DescriptionTable of Contents 6 Market Breakup by Product Type 6.1 Reagents and Consumables 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Equipment 6.2.1 Market Trends 6.2.2 Market Forecast 7 Market Breakup by Technique 7.1 Molecular Diagnostics 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Immunodiagnostics 7.2.1 Market Trends 7.2.2 Market Forecast 8 Market Breakup by Disease Type 8.1 Bacterial Enteric Disease 8.1.1 Market Trends Click here to visit the complete table of content with list of figures and tables: https://www.imarcgroup.com/enteric-disease-testing-market/toc
We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients
We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients
Report Description and Highlights Report Description © 2022 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.
Contact Us FOR MORE DETAILS Visit us at : https://www.imarcgroup.com Stay With Us: TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com